Tempus AI (NASDAQ:TEM) Trading Up 6.5% – Here’s Why

Tempus AI, Inc. (NASDAQ:TEM)’s stock price was up 6.5% during mid-day trading on Monday . The company traded as high as $69.95 and last traded at $69.5460. Approximately 2,871,974 shares traded hands during mid-day trading, a decline of 49% from the average daily volume of 5,625,994 shares. The stock had previously closed at $65.32.

Wall Street Analyst Weigh In

Several brokerages have weighed in on TEM. JPMorgan Chase & Co. cut their price target on Tempus AI from $85.00 to $80.00 and set a “neutral” rating for the company in a report on Monday, December 15th. Weiss Ratings reiterated a “sell (d-)” rating on shares of Tempus AI in a research note on Thursday, January 22nd. HC Wainwright decreased their price target on Tempus AI from $98.00 to $89.00 and set a “buy” rating on the stock in a research note on Friday, November 7th. Piper Sandler dropped their price objective on shares of Tempus AI from $105.00 to $80.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. Finally, Morgan Stanley increased their price objective on shares of Tempus AI from $80.00 to $85.00 and gave the stock an “overweight” rating in a report on Monday, December 1st. Six equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $87.20.

Tempus AI Stock Down 3.4%

The firm has a fifty day simple moving average of $68.81 and a 200-day simple moving average of $73.95. The company has a market capitalization of $11.49 billion, a PE ratio of -54.26 and a beta of 5.22. The company has a debt-to-equity ratio of 2.45, a quick ratio of 3.12 and a current ratio of 3.28.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings results on Tuesday, November 4th. The company reported ($0.11) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.16) by $0.05. The business had revenue of $334.21 million during the quarter, compared to the consensus estimate of $328.89 million. Tempus AI had a negative return on equity of 73.21% and a negative net margin of 18.45%.The business’s quarterly revenue was up 84.7% on a year-over-year basis. During the same period in the previous year, the business earned ($0.46) EPS. Equities research analysts anticipate that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Insider Transactions at Tempus AI

In other Tempus AI news, CEO Eric P. Lefkofsky sold 166,250 shares of the stock in a transaction on Thursday, December 18th. The shares were sold at an average price of $63.99, for a total transaction of $10,638,337.50. Following the transaction, the chief executive officer directly owned 8,974,783 shares of the company’s stock, valued at $574,296,364.17. This represents a 1.82% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, CFO James William Rogers sold 19,966 shares of the business’s stock in a transaction dated Thursday, December 11th. The stock was sold at an average price of $73.20, for a total value of $1,461,511.20. Following the transaction, the chief financial officer directly owned 111,250 shares of the company’s stock, valued at $8,143,500. This represents a 15.22% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 600,332 shares of company stock valued at $41,554,949 in the last quarter. 26.27% of the stock is owned by company insiders.

Hedge Funds Weigh In On Tempus AI

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TEM. Renaissance Capital LLC boosted its position in shares of Tempus AI by 26.9% during the third quarter. Renaissance Capital LLC now owns 84,166 shares of the company’s stock worth $6,793,000 after buying an additional 17,866 shares during the period. Pier 88 Investment Partners LLC purchased a new stake in shares of Tempus AI in the 2nd quarter valued at $286,000. Blair William & Co. IL lifted its stake in Tempus AI by 109.2% during the 2nd quarter. Blair William & Co. IL now owns 67,637 shares of the company’s stock worth $4,298,000 after acquiring an additional 35,303 shares in the last quarter. Trivium Point Advisory LLC boosted its holdings in Tempus AI by 670.7% during the 2nd quarter. Trivium Point Advisory LLC now owns 38,627 shares of the company’s stock valued at $2,454,000 after acquiring an additional 33,615 shares during the period. Finally, EFG Asset Management North America Corp. acquired a new position in Tempus AI in the 2nd quarter valued at about $2,233,000. 24.22% of the stock is currently owned by institutional investors and hedge funds.

About Tempus AI

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.